Tag Archives: Dr. Ing. Wendelin Wiedeking

Novartis shareholders approved Novartis Board of Directors’ proposed resolutions at the Group’s AGM

Shareholders approve 17th consecutive dividend increase to CHF 2.45 (+7%) per share for 2013, representing a payout of approximately 74% of net income from continuing operations Dr. Joerg Reinhardt confirmed by shareholders as Chairman of the Novartis Board of Directors … Read the full press release